Compare ASMB & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | NPCE |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 490.2M |
| IPO Year | 2010 | 2021 |
| Metric | ASMB | NPCE |
|---|---|---|
| Price | $35.44 | $14.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $44.20 | $18.33 |
| AVG Volume (30 Days) | ★ 289.7K | 137.8K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.78 | 29.03 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $99,986,000.00 |
| Revenue This Year | N/A | $0.90 |
| Revenue Next Year | $638.39 | $24.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $20.23 | $9.22 |
| 52 Week High | $39.71 | $19.60 |
| Indicator | ASMB | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 62.24 | 52.22 |
| Support Level | $32.57 | $13.75 |
| Resistance Level | $37.00 | $15.27 |
| Average True Range (ATR) | 1.56 | 0.62 |
| MACD | 0.02 | 0.11 |
| Stochastic Oscillator | 65.20 | 64.66 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.